Hikma Pharmaceuticals(HKMPY)
$44.18-0.08 (-0.19%)
HKMPY
Hikma Pharmaceuticals financials statements
$44.18
At close:-0.08 (-0.19%)
Want to see HKMPY full AI Analyst Report?
Hikma Pharmaceuticals (HKMPY) Income Statement
43 Followers
Hikma Pharmaceuticals Income Statement
Last quarter (Q2 2026), Hikma Pharmaceuticals's total revenue was $1.73B, an increase of 10.11% from the same quarter last year. In Q2, Hikma Pharmaceuticals's net income was $222.96M. See Hikma Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 3.36B | $ 3.13B | $ 2.88B | $ 2.52B | $ 2.55B | |
| $ 1.44B | $ 1.42B | $ 1.41B | $ 1.24B | $ 1.30B | |
| $ 808.00M | $ 803.00M | $ 1.04B | $ 956.00M | $ 719.00M | |
| Depreciation and Amortization | $ 212.50M | $ 197.00M | $ 198.00M | $ 193.00M | $ 144.00M |
| $ 781.82M | $ 727.00M | $ 566.00M | $ 691.00M | $ 743.00M | |
| $ 569.33M | $ 612.00M | $ 367.00M | $ 282.00M | $ 582.00M | |
| $ -49.11M | $ -158.00M | $ -86.00M | $ -49.00M | $ -39.00M | |
| $ 520.21M | $ 454.00M | $ 281.00M | $ 233.00M | $ 543.00M | |
| $ 402.94M | $ 359.00M | $ 190.00M | $ 188.00M | $ 421.00M | |
| Per Share Metrics | |||||
| Basic EPS | $ 3.66 | $ 3.24 | $ 1.70 | $ 1.68 | $ 3.64 |
| Diluted EPS | $ 3.62 | $ 3.22 | $ 1.72 | $ 1.68 | $ 3.62 |
| Weighted Average Shares Outstanding | 110.29M | 110.67M | 111.18M | 111.86M | 115.50M |
| Weighted Average Shares Outstanding (Diluted) | 111.34M | 111.75M | 111.18M | 112.50M | 116.50M |
Currency in USD
